Home
Browse
Search
Statistics
About
Usage
PMID: 21143116
He SM, Li R, Kanwar JR, Zhou SF
Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1).
Curr Med Chem. 2011;18(3):439-81.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
335
ABCC2 p.Leu23Arg
X
ABCC2 p.Leu23Arg 21143116:335:134
status:
NEW
view ABCC2 p.Leu23Arg details
ABCC2 p.Leu23Pro
X
ABCC2 p.Leu23Pro 21143116:335:121
status:
NEW
view ABCC2 p.Leu23Pro details
Some other NSAIDs including sulindac were found to have a similar effect in human lung cancer cell lines DLKP, A549, COR
L23P
and COR
L23R
and in a human leukaemia line HL60/ADR [229], although it is unrelated to the action of these drugs on cyclooxygenases.
Login to comment
654
ABCC1 p.Asp793Glu
X
ABCC1 p.Asp793Glu 21143116:654:4
status:
NEW
view ABCC1 p.Asp793Glu details
ABCC1 p.Glu1455Asp
X
ABCC1 p.Glu1455Asp 21143116:654:77
status:
NEW
view ABCC1 p.Glu1455Asp details
The
Asp793Glu
mutation in NBD1 enhanced its hydrolytic capacity, whereas the
Glu1455Asp
mutation in NBD2 resulted in an increased affinity of NBD2 for ATP, but a decreased hydrolytic activity [322].
Login to comment
671
ABCC1 p.Asp793Glu
X
ABCC1 p.Asp793Glu 21143116:671:4
status:
NEW
view ABCC1 p.Asp793Glu details
The
Asp793Glu
mutant of NBD1 showed increased hydrolytic capacity but had occlusion of the resultant ADP in the absence of vanadates [322].
Login to comment
673
ABCC1 p.Glu1455Asp
X
ABCC1 p.Glu1455Asp 21143116:673:4
status:
NEW
view ABCC1 p.Glu1455Asp details
The
Glu1455Asp
mutant with a reciprocal mutation of NBD2 exhibited an increased affinity for both azido-ATP and -ADP.
Login to comment
711
ABCC1 p.Glu1089Gln
X
ABCC1 p.Glu1089Gln 21143116:711:196
status:
NEW
view ABCC1 p.Glu1089Gln details
More NH2-proximal regions of TMD1 also appear to be involved in LY475776 binding since tryptic fragments corresponding to TM12/13 and TM14/15 are photolabeled, and photolabeling is reduced in the
Glu1089Gln
mutant of TM14 [270, 271].
Login to comment
720
ABCC1 p.Trp222Leu
X
ABCC1 p.Trp222Leu 21143116:720:71
status:
NEW
view ABCC1 p.Trp222Leu details
ABCC1 p.Trp223Leu
X
ABCC1 p.Trp223Leu 21143116:720:82
status:
NEW
view ABCC1 p.Trp223Leu details
ABCC1 p.Arg230Ala
X
ABCC1 p.Arg230Ala 21143116:720:96
status:
NEW
view ABCC1 p.Arg230Ala details
Membrane vesicles prepared from cells expressing mutated MRP1/ABCC1 at
Trp222Leu
,
Trp223Leu
, or
Arg230Ala
within L0 could transport SN-38 (active metabolite of irinotecan), but not LTC4 or E217 G which are transported by MRP1/ABCC1 in a GSH-dependent manner, and could not be photolabeled with 11-azidophenyl agosterol A [279].
Login to comment
726
ABCC1 p.Glu1144Ala
X
ABCC1 p.Glu1144Ala 21143116:726:1103
status:
NEW
view ABCC1 p.Glu1144Ala details
ABCC1 p.Asp1179Ala
X
ABCC1 p.Asp1179Ala 21143116:726:1185
status:
NEW
view ABCC1 p.Asp1179Ala details
ABCC1 p.Lys1181Ala
X
ABCC1 p.Lys1181Ala 21143116:726:1210
status:
NEW
view ABCC1 p.Lys1181Ala details
ABCC1 p.Arg1166Ala
X
ABCC1 p.Arg1166Ala 21143116:726:1160
status:
NEW
view ABCC1 p.Arg1166Ala details
These include Cys43 in TM1 [171], Thr73 in CL1 [366], Trp222 in L0 [279], Trp223 in L0 [279], Arg230 in L0 [279], Trp261 in L0 [271, 302, 338], Lys267 in L0 [271, 302, 338], Lys319 in TM6 [339], Tyr324 in TM6 [301], Lys332 in TM6 [166, 339-341], His335 in TM6, Asp336 in TM6 [339], Lys347 in TM6 [339], Lys396 in TM7 [339], Arg433 in TM8 [363], Asp436 in TM8 [339], Trp445 in TM8, Trp459 in TM8, Pro478 in TM9, Thr550 in TM10 [343], Trp553 in TM10 [344], Thr556 in TM10 [343], Pro557 in TM10 [345], Tyr568 in TM10 [343], Arg593 in TM11 [339], Phe594 in TM11 [300], Asn597 in TM11, Ser604 in TM11, Ser605 in TM11, Trp653 in NBD1 [351], Lys684 in Walker A motif of NBD1 [350, 364], Ser685 in Walker A motif of NBD1 [353], Arg723 in NBD1 [366], Gly771 in the ABC signature (C motif) of NBD1 [364], Asp792 in Walker B motif of NBD1 [361], Asp793 in Walker B motif of NBD1 [353], Ala989 in TM12 [367], Pro1120 in TM13, Pro1121 in TM13, Arg1058 at TM13/CL6 interface [366], Glu1089 in TM14, Lys1092 in TM14, Ser1097 in TM14, Asn1100 in TM14, Arg1138 in TM15 [354], Lys1141 in CL7 [354], Arg1142 in CL7 [354],
Glu1144Ala
in CL7 [355], Pro1150 in CL7 [345, 347, 348],
Arg1166Ala
in CL7 [355],
Asp1179Ala
in CL7 [355],
Lys1181Ala
in CL7 [355], Asp1183 in CL7 [355], Tyr1189 in CL7 [368], Tyr1190 in CL7 [368], Arg1197 in TM16 [357], Trp1198 in TM16 [344], Arg1202 in TM16 [357], Glu1204 in TM16 [357], Tyr1236 in TM17, Thr1241 in TM17, Thr1242 in TM17, Tyr1243 in TM17, Asn1245 in TM17, Trp1246 in TM17 [166, 339-341], Arg1249 in TM17 [342], Tyr1302 in NBD2 [351], Lys1333 in Walker A motif of NBD2 [350], Gly1433 in the ABC signature motif of NBD2 [352, 364], Glu1455 in Walker B motif of NBD2 [322], and His1486 in NBD2 [349].
Login to comment
735
ABCC1 p.Arg433Ser
X
ABCC1 p.Arg433Ser 21143116:735:39
status:
NEW
view ABCC1 p.Arg433Ser details
The naturally occurring replacement of
Arg433 by Ser
(neutral) at the interface of CL4 and TM8 caused a 2-fold decrease in LTC4 and estrone sulfate transport but were 2.1-fold more resistant to doxorubicin while while resistance to etoposide (VP-16) and vincristine remained unchanged [363].
Login to comment
739
ABCC1 p.Arg1138Glu
X
ABCC1 p.Arg1138Glu 21143116:739:105
status:
NEW
view ABCC1 p.Arg1138Glu details
In contarst, the mutations showed minor to moderate effect on MTX transport, with a maximum decrease for
Arg1138Glu
).
Login to comment
742
ABCC1 p.Lys1141Arg
X
ABCC1 p.Lys1141Arg 21143116:742:21
status:
NEW
view ABCC1 p.Lys1141Arg details
ABCC1 p.Lys1141Glu
X
ABCC1 p.Lys1141Glu 21143116:742:21
status:
NEW
view ABCC1 p.Lys1141Glu details
Notably, mutation of
Lys1141 to either Glu
or Arg impaired MRP1/ABCC1 expression and routing to the plasma membrane [354].
Login to comment
743
ABCC1 p.Lys1141Arg
X
ABCC1 p.Lys1141Arg 21143116:743:216
status:
NEW
view ABCC1 p.Lys1141Arg details
ABCC1 p.Lys1141Glu
X
ABCC1 p.Lys1141Glu 21143116:743:16
status:
NEW
view ABCC1 p.Lys1141Glu details
ABCC1 p.Lys1141Glu
X
ABCC1 p.Lys1141Glu 21143116:743:201
status:
NEW
view ABCC1 p.Lys1141Glu details
Substitution of
Lys1141 with Glu
(negatively chages) at TM15/CL7 interface decreased LTC4 transport by 70%, but an Arg substitution (positively charged) at this position did not; GSH transport by both
Lys1141Glu
and
Lys1141Arg
mutants was decreased by 40%, suggesting that the presence of a positive charge at Lys1141 was sufficient for LTC4 transport, whereas the less bulky side chain of Lys itself seemed important for GSH transport [354].
Login to comment
744
ABCC1 p.Lys1141Glu
X
ABCC1 p.Lys1141Glu 21143116:744:19
status:
NEW
view ABCC1 p.Lys1141Glu details
ABCC1 p.Arg1138Lys
X
ABCC1 p.Arg1138Lys 21143116:744:51
status:
NEW
view ABCC1 p.Arg1138Lys details
ABCC1 p.Arg1138Glu
X
ABCC1 p.Arg1138Glu 21143116:744:4
status:
NEW
view ABCC1 p.Arg1138Glu details
ABCC1 p.Arg1142Glu
X
ABCC1 p.Arg1142Glu 21143116:744:63
status:
NEW
view ABCC1 p.Arg1142Glu details
ABCC1 p.Arg1142Lys
X
ABCC1 p.Arg1142Lys 21143116:744:79
status:
NEW
view ABCC1 p.Arg1142Lys details
The
Arg1138Glu
and
Lys1141Glu
mutants, but not the
Arg1138Lys
,
Arg1142Glu
, and
Arg1142Lys
mutants, showed a >50% decrease in binding to [3 H]LTC4.
Login to comment
745
ABCC1 p.Lys1141Arg
X
ABCC1 p.Lys1141Arg 21143116:745:19
status:
NEW
view ABCC1 p.Lys1141Arg details
All mutants except
Lys1141Arg
showed substantially reduced trapping of 8-azido-[ 32P]ATP (40-60% that of wild-type MRP1), implicating that the ability of these mutants at TM15/CL7 interface to hydrolyze ATP is impaired and consequently disrupt the transport cycle and cause a decrease in transport activity.
Login to comment
751
ABCC1 p.Pro51Ala
X
ABCC1 p.Pro51Ala 21143116:751:53
status:
NEW
view ABCC1 p.Pro51Ala details
ABCC1 p.Pro42Ala
X
ABCC1 p.Pro42Ala 21143116:751:44
status:
NEW
view ABCC1 p.Pro42Ala details
The transport activity of the double mutant
Pro42Ala
/
Pro51Ala
was reduced by >80%.
Login to comment
755
ABCC1 p.Pro1150Ala
X
ABCC1 p.Pro1150Ala 21143116:755:40
status:
NEW
view ABCC1 p.Pro1150Ala details
Compared with wild-type MRP1/ABCC1, the
Pro1150Ala
mutant showed decreased LTC4, estrone sulfate, and GSH transport but substantially increased E217 G and MTX transport [345].
Login to comment
757
ABCC1 p.Pro1150Ala
X
ABCC1 p.Pro1150Ala 21143116:757:15
status:
NEW
view ABCC1 p.Pro1150Ala details
In the case of
Pro1150Ala
mutant, vanadate-induced trapping of [ 32 P]8N3ADP was greatly diminished relative to wild-type MRP1, while photolabeling of this mutant with [ 32 P]8N3ATP under nonhydrolytic conditions remained unchanged [345].
Login to comment
758
ABCC1 p.Pro1150Ala
X
ABCC1 p.Pro1150Ala 21143116:758:99
status:
NEW
view ABCC1 p.Pro1150Ala details
ABCC1 p.Pro1150Leu
X
ABCC1 p.Pro1150Leu 21143116:758:28
status:
NEW
view ABCC1 p.Pro1150Leu details
ABCC1 p.Pro1150Gly
X
ABCC1 p.Pro1150Gly 21143116:758:4
status:
NEW
view ABCC1 p.Pro1150Gly details
ABCC1 p.Pro1150Val
X
ABCC1 p.Pro1150Val 21143116:758:43
status:
NEW
view ABCC1 p.Pro1150Val details
ABCC1 p.Pro1150Ile
X
ABCC1 p.Pro1150Ile 21143116:758:16
status:
NEW
view ABCC1 p.Pro1150Ile details
The
Pro1150Gly
,
Pro1150Ile
,
Pro1150Leu
and
Pro1150Val
mutants exhibited a phenotype similar to the
Pro1150Ala
mutant with respect to organic anion transport and [ 32 P]8N3ATP photolabeling [347].
Login to comment
763
ABCC1 p.Trp1246Phe
X
ABCC1 p.Trp1246Phe 21143116:763:29
status:
NEW
view ABCC1 p.Trp1246Phe details
In contrast, substitution of
Trp1246 with Phe
, Tyr, Ala, or Cys selectively eliminated E217 G and NNAL-O-glucuronide transport and drug resistance but showed little or no effect on LTC4 and GSH transport [166, 341, 371].
Login to comment
765
ABCC1 p.Trp1246Cys
X
ABCC1 p.Trp1246Cys 21143116:765:19
status:
NEW
view ABCC1 p.Trp1246Cys details
ABCC1 p.Lys332Leu
X
ABCC1 p.Lys332Leu 21143116:765:5
status:
NEW
view ABCC1 p.Lys332Leu details
Both
Lys332Leu
and
Trp1246Cys
mutants were as sensitive as wild-type MRP1/ABCC1 to MK-571, LY171883, and the potent MRP1/ABCC1 inhibitor 6-[4 -carboxyphenylthio]-5[S]- hydroxy-7[E], 11[Z]14[Z]-eicosatetrenoic acid (BAY u9773, a leukotriene-like dual antagonist that acts on both CysLT1 and CysLT2 receptors) [341].
Login to comment
766
ABCC1 p.Lys332Leu
X
ABCC1 p.Lys332Leu 21143116:766:121
status:
NEW
view ABCC1 p.Lys332Leu details
ABCC1 p.Lys332Leu
X
ABCC1 p.Lys332Leu 21143116:766:218
status:
NEW
view ABCC1 p.Lys332Leu details
MK-571 and LY171883 were moderately (2-fold) less potent inhibitors of E217 G uptake by wild-type MRP1/ABCC1 than by the
Lys332Leu
mutant, but LY465803 showed 16-fold greater potency to inhibit wild-type compared with
Lys332Leu
mutant.
Login to comment
767
ABCC1 p.Lys332Leu
X
ABCC1 p.Lys332Leu 21143116:767:149
status:
NEW
view ABCC1 p.Lys332Leu details
In a similar manner, the GSH derivative S-decyl-GSH and GSSG inhibited wild-type MRP1/ABCC1 activity with IC50 >100-fold and >30-fold lower than for
Lys332Leu
, respectively [341].
Login to comment
768
ABCC1 p.Trp1246Cys
X
ABCC1 p.Trp1246Cys 21143116:768:164
status:
NEW
view ABCC1 p.Trp1246Cys details
ABCC1 p.Lys332Leu
X
ABCC1 p.Lys332Leu 21143116:768:76
status:
NEW
view ABCC1 p.Lys332Leu details
In contrast to its more potent inhibitory effect on E217 G transport by the
Lys332Leu
mutant, MK-571 was a less potent inhibitor ( 3-fold) of LTC4 transport by the
Trp1246Cys
mutant than by wild-type MRP1.
Login to comment
769
ABCC1 p.Trp1246Cys
X
ABCC1 p.Trp1246Cys 21143116:769:106
status:
NEW
view ABCC1 p.Trp1246Cys details
ABCC1 p.Lys332Leu
X
ABCC1 p.Lys332Leu 21143116:769:20
status:
NEW
view ABCC1 p.Lys332Leu details
However, similar to
Lys332Leu
, the inhibitory potency of BAY u9773 for LTC4 transport by wild-type and
Trp1246Cys
was comparable.
Login to comment
781
ABCC1 p.Trp361Ala
X
ABCC1 p.Trp361Ala 21143116:781:0
status:
NEW
view ABCC1 p.Trp361Ala details
Ala substitution of Trp361
in TM7 and Trp459 in TM9 only resulted in more moderate changes in trasnport activity.
Login to comment
792
ABCC1 p.Tyr440Phe
X
ABCC1 p.Tyr440Phe 21143116:792:4
status:
NEW
view ABCC1 p.Tyr440Phe details
The
Tyr440Phe
mutant expressed in Sf21 cells showed a 5-fold higher Km for LTC4 and substantially reduced photolabeling of MRP1/ABCC1 by both [3 H]LTC4 and the GSH derivative, azidophenacyl-[35 S]GSH [374].
Login to comment
794
ABCC1 p.Tyr440Phe
X
ABCC1 p.Tyr440Phe 21143116:794:17
status:
NEW
view ABCC1 p.Tyr440Phe details
ABCC1 p.Tyr440Phe
X
ABCC1 p.Tyr440Phe 21143116:794:139
status:
NEW
view ABCC1 p.Tyr440Phe details
ABCC1 p.Ile441Leu
X
ABCC1 p.Ile441Leu 21143116:794:28
status:
NEW
view ABCC1 p.Ile441Leu details
ABCC1 p.Met443Leu
X
ABCC1 p.Met443Leu 21143116:794:39
status:
NEW
view ABCC1 p.Met443Leu details
In addition, the
Tyr440Phe
,
Ile441Leu
,
Met443Leu
mutations decreased resistance to vincristine and etoposide 2-to 3-fold, whereas only the
Tyr440Phe
mutant displayed a major decrease in resistance to doxorubicin [374].
Login to comment
806
ABCC1 p.Lys1141Glu
X
ABCC1 p.Lys1141Glu 21143116:806:15
status:
NEW
view ABCC1 p.Lys1141Glu details
Replacement of
Lys1141 with Glu
also impaired the expression of MRP1/ABCC1 at the plasma membrane and reduced its transport activity.
Login to comment
807
ABCC1 p.Gly1161Pro
X
ABCC1 p.Gly1161Pro 21143116:807:31
status:
NEW
view ABCC1 p.Gly1161Pro details
ABCC1 p.Glu1157Leu
X
ABCC1 p.Glu1157Leu 21143116:807:20
status:
NEW
view ABCC1 p.Glu1157Leu details
The double-mutant
Glu1157Leu
/
Gly1161Pro
showed no activity for LTC4 and was not labeled by the photoaffinity ligand azidoAgosterol A [365].
Login to comment
809
ABCC1 p.Asp1183Ala
X
ABCC1 p.Asp1183Ala 21143116:809:19
status:
NEW
view ABCC1 p.Asp1183Ala details
ABCC1 p.Arg1166Ala
X
ABCC1 p.Arg1166Ala 21143116:809:4
status:
NEW
view ABCC1 p.Arg1166Ala details
The
Arg1166Ala
and
Asp1183Ala
/Glu mutants were poorly expressed, probably by affecting the proper folding of the protein during its biosynthesis.
Login to comment
813
ABCC1 p.Glu1144Ala
X
ABCC1 p.Glu1144Ala 21143116:813:19
status:
NEW
view ABCC1 p.Glu1144Ala details
ABCC1 p.Asp1179Ala
X
ABCC1 p.Asp1179Ala 21143116:813:31
status:
NEW
view ABCC1 p.Asp1179Ala details
ABCC1 p.Lys1181Ala
X
ABCC1 p.Lys1181Ala 21143116:813:47
status:
NEW
view ABCC1 p.Lys1181Ala details
The single mutants
Glu1144Ala
,
Asp1179Ala
, and
Lys1181Ala
) and the triple mutant 1169AAQA showed only moderate and substrate-selective changes in transport activity [355].
Login to comment
816
ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 21143116:816:88
status:
NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 21143116:816:225
status:
NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Thr73Ile
X
ABCC1 p.Thr73Ile 21143116:816:105
status:
NEW
view ABCC1 p.Thr73Ile details
ABCC1 p.Arg1058Gln
X
ABCC1 p.Arg1058Gln 21143116:816:366
status:
NEW
view ABCC1 p.Arg1058Gln details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 21143116:816:206
status:
NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Arg433Ser
X
ABCC1 p.Arg433Ser 21143116:816:188
status:
NEW
view ABCC1 p.Arg433Ser details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 21143116:816:346
status:
NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Val353Met
X
ABCC1 p.Val353Met 21143116:816:156
status:
NEW
view ABCC1 p.Val353Met details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 21143116:816:327
status:
NEW
view ABCC1 p.Ala989Thr details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 21143116:816:122
status:
NEW
view ABCC1 p.Ser92Phe details
ABCC1 p.Arg230Asn
X
ABCC1 p.Arg230Asn 21143116:816:139
status:
NEW
view ABCC1 p.Arg230Asn details
ABCC1 p.Val1146Ile
X
ABCC1 p.Val1146Ile 21143116:816:385
status:
NEW
view ABCC1 p.Val1146Ile details
ABCC1 p.Thr1401Met
X
ABCC1 p.Thr1401Met 21143116:816:469
status:
NEW
view ABCC1 p.Thr1401Met details
ABCC1 p.Thr1337Ala
X
ABCC1 p.Thr1337Ala 21143116:816:404
status:
NEW
view ABCC1 p.Thr1337Ala details
ABCC1 p.Ala861Thr
X
ABCC1 p.Ala861Thr 21143116:816:293
status:
NEW
view ABCC1 p.Ala861Thr details
There are at least 15 naturally occurring mutations identified in MRP1/ABCC1, including
Cys43Ser
in TM1,
Thr73Ile
in CL1,
Ser92Phe
in TM2,
Arg230Asn
in L0,
Val353Met
at TM6/TM7 interface,
Arg433Ser
in TM8,
Gly671Val
in TM11,
Arg723Gln
located between the Walker A and Walker B motifs of NBD1,
Ala861Thr
at NBD1/TM12 interface,
Ala989Thr
in TM12,
Cys1047Ser
in TM13,
Arg1058Gln
in CL7,
Val1146Ile
in CL7,
Thr1337Ala
between the Walker A and Walker B motifs of NBD2, and
Thr1401Met
, and many of them have been found to affect its transport activity [171, 362, 363, 366, 367, 377-384].
Login to comment
818
ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 21143116:818:4
status:
NEW
view ABCC1 p.Cys43Ser details
The
Cys43Ser
mutant in TM1 (128G>C in exon 2) exhibited impaired plasma membrane location of the transporter, with a 2.5-fold decrease in arsenite resistance and a lower vincristine resistance [171].
Login to comment
819
ABCC1 p.Arg433Ser
X
ABCC1 p.Arg433Ser 21143116:819:61
status:
NEW
view ABCC1 p.Arg433Ser details
A naturally-occurring mutation of 1299G>T in exon 10 causing
Arg433Ser
in TM8 of TMD1 resulted in decreased transport of LTC4 and increased resistance to doxorubicin [363].
Login to comment
820
ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 21143116:820:5
status:
NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 21143116:820:25
status:
NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Thr73Ile
X
ABCC1 p.Thr73Ile 21143116:820:15
status:
NEW
view ABCC1 p.Thr73Ile details
ABCC1 p.Arg1058Gln
X
ABCC1 p.Arg1058Gln 21143116:820:40
status:
NEW
view ABCC1 p.Arg1058Gln details
When
Cys43Ser
,
Thr73Ile
,
Arg723Gln
, and
Arg1058Gln
were separately transfected in CHO-K1 or HEK293 cells, the cells displayed altered resistance profiles to a panel of anticancer drugs compared to the wild-type [366].
Login to comment
821
ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 21143116:821:17
status:
NEW
view ABCC1 p.Arg723Gln details
In HEK293 cells,
Arg723Gln
confers lower resistance to all drugs compared with wild-types.
Login to comment
822
ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 21143116:822:17
status:
NEW
view ABCC1 p.Arg723Gln details
In CHO-K1 cells,
Arg723Gln
significantly decreased resistance to all drugs tested except cisplatin, paclitaxel and MTX.
Login to comment
823
ABCC1 p.Arg1058Gln
X
ABCC1 p.Arg1058Gln 21143116:823:4
status:
NEW
view ABCC1 p.Arg1058Gln details
The
Arg1058Gln
mutant showed a significant decrease in resistance to anthracyclines and etoposide in HEK293 cells [366].
Login to comment
824
ABCC1 p.Arg1058Gln
X
ABCC1 p.Arg1058Gln 21143116:824:21
status:
NEW
view ABCC1 p.Arg1058Gln details
In CHO-K1 cells, the
Arg1058Gln
mutant conferred a lower resistance to vinblastine, anthracyclines, etoposide and MTX.
Login to comment
825
ABCC1 p.Thr73Ile
X
ABCC1 p.Thr73Ile 21143116:825:21
status:
NEW
view ABCC1 p.Thr73Ile details
In HEK293 cells, the
Thr73Ile
mutation displayed a lower resistance to vincristine and MTX [366].
Login to comment
828
ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 21143116:828:36
status:
NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Thr73Ile
X
ABCC1 p.Thr73Ile 21143116:828:63
status:
NEW
view ABCC1 p.Thr73Ile details
For example, the frequencies of the
Arg723Gln
A allele and the
Thr73Ile
T allele in Chinese population were higher than the Caucasians [366].
Login to comment